期刊文献+

抗肿瘤药物治疗冠状动脉疾病研究进展

Research progress for antitumor drug treating coronary artery disease
下载PDF
导出
摘要 本文总结抗肿瘤药物治疗冠状动脉疾病研究的进展。查阅近年来国内外关于抗肿瘤药物治疗冠状动脉疾病的相关文献,就其研究进展进行综述。抗肿瘤药物治疗冠状动脉疾病的机理是多层次、多位点的。某些抗肿瘤药物有望成为治疗冠状动脉疾病的新靶点。 The present article summarizes research progress for anti-tumor drug relating coronary artery disease, reviews domestic and foreign relevant literature about it and makes a review about its research progress. Its mechanism is multi-level and multi-site. Some anti-tumor drug are expected to be new targets of treating coronary artery disease.
出处 《心血管康复医学杂志》 CAS 2018年第1期107-110,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 抗肿瘤药 炎症 冠状动脉疾病 Antineoplastic agents Inflammation Coronary artery disease
  • 引文网络
  • 相关文献

参考文献2

二级参考文献42

  • 1王长希,刘龙山,陈立中,吴培根,费继光,邱江,邓素雄,郑克立,纪玉莲,朱兰英,沈清瑞,何晓顺.雷帕霉素治疗肾移植术后肿瘤八例[J].中华器官移植杂志,2005,26(5):278-279. 被引量:8
  • 2Ocker M, Herold C, Ganslmayer M, et al. The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Iht J Cancer 2003;107:453-9.
  • 3Higuchi E, Chandraratna RA, Hong WK, et al. Induction of TIG3,a putative class Ⅱ tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 2003;22:4627-35.
  • 4Choi Y, Kim SY, Kim SH, et al. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 2003;107:145-8.
  • 5Re ynolds CP, Matthay KK, Villablanca JG, et al. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 2003; 197:185-92.
  • 6Song L, Cheng T. Effects of 1,25-dihydroxyvitamin D3 analogue 1,24(OH)2-2-ene-cyclopropyl D3 on proliferation and differentiation of a human megakaryoblastic leukemia cell line. Biochem Pharmac 1992;43:2292-5.
  • 7Xu MJ, Fang GE, Liu YJ, et al. Effects of glucocorticoid on proliferation, differentiation, and glucocorticoid receptor expression in human ovarian carcinoma cell line 3AO. Acta Pharmacol Sin 2002;23:819-23.
  • 8Ahlgren JD, Ellison NM, Gottlieb R J, et al. Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase Ⅱ trials of the mid-Atlantic oncology program. J Clinic Oncology 1993;11:1957-68.
  • 9Zhang D, Holmes WF, Wu S, et al. Retinoids and ovarian cancer.J Cell Physiol 2000;186:1-20.
  • 10Bell BA, Findley HW, Krischer J, et al. Phase Ⅱ study of 13-cisretinoic acid in pediatric patients with acute nonlymphocytic leukemia. J Immunother 1991;10:77-83.

共引文献4

相关主题

;
使用帮助 返回顶部